Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation

Gut

Volumn 48, Issue 3, 2001, Pages 314-319

  Endlicher, E ^a   Knuechel, R ^a   Hauser, T ^a   Szeimies, R M ^a   Scholmerich J ^a   Messmann, H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 Aminolaevulinic acid; Barrett's oesophagus; Dysplasia; Fluorescence endoscopy

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DYSPLASIA; EARLY DIAGNOSIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; HYPOTENSION; MALE; NAUSEA; PRIORITY JOURNAL; SKIN TOXICITY; VOMITING;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PROTOPORPHYRINS; SENSITIVITY AND SPECIFICITY;

EID: 0035062841     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.3.314     Document Type: Article

References (24)

1. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus
2. Endoscopic surveillance for patients with Barrett's esophagus: Does the risk justify the practice?
3. Barrett's esophagus: Development of dysplasia and adenocarcinoma
4. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
5. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus
6. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology
7. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
8. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia
9. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
10. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - A pilot study
11. Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid
12. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization
13. Enhancement of the PDT effect in patients with esophageal cancer by laser light fractionation
14. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus
15. Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence
16. Clinical spectral characterisation of colonic mucosal lesions using autofluorescence and delta aminolevulinic acid sensitisation
17. Fluorescence localization of early colonic cancer in the rat by hematoporphyrin derivative
18. Photodetection of carcinoma of the colon in a rat model: A pilot study
19. Endoscopic and microscopic fluorescence studies in patients with ulcerative colitis after 5-amino laevulinic acid photosensitisation
20. Endoscopic investigation of Barrett's esophagus by laser-induced fluorescence spectroscopy
21. Influence of subcellular protoporphyrin IX (PPIX) localisation on phototoxicity in different human colon carcinoma cell lines
22. Cellular fluorescence of the endogenous photosensitiser protoporphyrin IX following exposure to 5-aminolevulinic acid
23. Localization of dysplasia using real-time light-induced fluorescence endoscopy
24. Accuracy of fluorescence imaging of dysplasia in Barrett's esophagus